What is the primary function of the myenteric plexus?
What is true about bilirubin?
Which of the following statements about enterohepatic circulation is FALSE?
Which of the following controls the secretion in the gastrointestinal tract?
The absorption of glucose from the gut into intestinal mucosal cells is coupled to Na+,K+ ATPase. In contrast, the movement of glucose from the intestinal epithelial cells into the submucosal bloodstream occurs through passive transport. Given these facts, which of the following statements can be true at one time or another?
Short-chain fatty acids are absorbed by:
Which of the following does not help in the prevention of reflux esophagitis?
Which of the following is the origin of electrical slow wave activity in gastrointestinal tract smooth muscle?
The triad originally described for Zollinger-Ellison syndrome is characterized by which of the following combinations?
Slow waves in the gastrointestinal tract are generated by which of the following?
Explanation: ### Explanation The enteric nervous system (ENS) is composed of two primary plexuses: the **Myenteric (Auerbach’s) plexus** and the **Submucosal (Meissner’s) plexus**. **Why "Motor" is Correct:** The myenteric plexus is located between the inner circular and outer longitudinal muscle layers of the muscularis externa. Its primary function is **motor control** of the gastrointestinal tract. When stimulated, it increases the intensity and rate of rhythmical contractions and the velocity of conduction of excitatory waves along the gut wall. It is the principal coordinator of **peristalsis**. **Analysis of Incorrect Options:** * **A & D (Sympathetic/Parasympathetic):** While the myenteric plexus receives extrinsic input from the autonomic nervous system (parasympathetic stimulates; sympathetic inhibits), it is an intrinsic system. It can function independently of these nerves, making it incorrect to label its primary function as purely sympathetic or parasympathetic. * **C (Mixed):** While the ENS as a whole has sensory and motor components, the myenteric plexus is specifically specialized for **motility**. In contrast, the Submucosal (Meissner’s) plexus is primarily responsible for sensory functions, local secretion, and blood flow. **High-Yield Clinical Pearls for NEET-PG:** * **Hirschsprung Disease:** Congenital absence of ganglion cells in the myenteric and submucosal plexuses (due to failure of neural crest cell migration), leading to a functional obstruction and "megacolon." * **Achalasia Cardia:** Characterized by the loss of inhibitory nitrergic neurons in the myenteric plexus of the lower esophageal sphincter (LES). * **Neurotransmitters:** The myenteric plexus uses **Acetylcholine** for contraction and **Nitric Oxide (NO)/VIP** for relaxation.
Explanation: ### Explanation **1. Why Option B is Correct:** Bilirubin (specifically unconjugated bilirubin) has a high chemical affinity for **elastin**, a protein found in the connective tissue of the skin, sclera, and mucous membranes. This explains why jaundice (icterus) is most clinically apparent in the **sclera** of the eye, which is rich in elastin. This binding is reversible but strong enough to cause the characteristic yellow discoloration when serum levels exceed 2 mg/dL. **2. Why Other Options are Incorrect:** * **Option A:** In the process of bilirubin metabolism (Uptake → Conjugation → Excretion), the **rate-limiting step is the excretion** of conjugated bilirubin into the bile canaliculi (mediated by the MRP2 transporter). Conjugation itself is a high-capacity process. * **Option C:** In a healthy individual, **unconjugated (indirect) bilirubin** is the predominant form in the blood (approx. 80-90%). Conjugated bilirubin is water-soluble and is promptly excreted into the bile; its presence in high amounts in the blood usually indicates pathology (obstructive jaundice). * **Option D:** Since A and C are incorrect, this option is invalid. **3. NEET-PG High-Yield Clinical Pearls:** * **Rate-limiting step defect:** A defect in the excretion of conjugated bilirubin (the rate-limiting step) leads to **Dubin-Johnson Syndrome**. * **Conjugation enzyme:** Bilirubin is conjugated with glucuronic acid by the enzyme **UDP-glucuronosyltransferase (UGT1A1)**. * **Kernicterus:** Unconjugated bilirubin is lipid-soluble and can cross the blood-brain barrier in neonates, depositing in the basal ganglia. * **Van den Bergh Reaction:** Used to differentiate types; Conjugated bilirubin gives a **Direct** reaction, while Unconjugated requires alcohol to react (**Indirect**).
Explanation: ### Explanation **Why Option C is the Correct (False) Statement:** Enterohepatic circulation is a highly efficient recycling process, but it is **not universal** for all bile components. While bile salts are recycled with ~95% efficiency, other components like **conjugated bilirubin** are not reabsorbed in the ileum. Instead, bilirubin is converted by gut bacteria into urobilinogen; a small portion undergoes enterohepatic cycling, but most is excreted in feces (as stercobilin) or urine (as urobilin). Additionally, cholesterol and certain phospholipids are partially excreted. Therefore, saying "all components" are reabsorbed is physiologically incorrect. **Analysis of Other Options:** * **Option A (True):** The reabsorption of bile salts in the terminal ileum occurs via the **Apical Sodium-dependent Bile acid Transporter (ASBT)**. This is a secondary active transport mechanism (sodium-bile salt cotransport). * **Option B (True):** The body maintains a small bile acid pool (approx. 2–4g). To meet digestive needs, ~95% of these salts are reabsorbed in the distal ileum and returned to the liver via the portal vein. * **Option D (True):** The entire bile acid pool typically circulates **6 to 10 times per day**, especially following meals, to facilitate lipid digestion and absorption. **NEET-PG High-Yield Pearls:** * **Primary Site:** The **Terminal Ileum** is the specific site for active bile salt reabsorption. Resection of the terminal ileum (e.g., in Crohn’s disease) leads to bile acid malabsorption, resulting in **steatorrhea** and **choleretic diarrhea**. * **Rate-Limiting Step:** The synthesis of new bile acids from cholesterol is regulated by the enzyme **7-alpha-hydroxylase**, which is inhibited by recycled bile salts (negative feedback). * **Clinical Link:** Bile acid sequestrants (e.g., Cholestyramine) work by interrupting this circulation, forcing the liver to use more cholesterol to synthesize new bile salts, thereby lowering LDL levels.
Explanation: The Enteric Nervous System (ENS) is often referred to as the "brain of the gut" and consists of two primary plexuses located within the walls of the gastrointestinal tract. **Correct Answer: C. Meissner's plexus** Meissner’s plexus, also known as the **Submucosal plexus**, is located in the submucosal layer of the GI tract. Its primary function is to regulate local **secretions** (mucus, enzymes, and hormones) and control local blood flow. It also plays a role in sensing the luminal environment through mechanoreceptors and chemoreceptors. **Explanation of Incorrect Options:** * **A & B. Myenteric plexus (Auerbach's plexus):** These terms are synonymous. This plexus is located between the inner circular and outer longitudinal muscle layers (the muscularis externa). Its primary role is the regulation of **gastrointestinal motility** (peristalsis and sphincter tone). While it influences movement, it does not directly control secretion. * **D. All of the above:** This is incorrect because the functions of the two plexuses are distinct and anatomically separated. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** **M**eissner’s = **M**ucosal/Secretory; **A**uerbach’s = **A**ction (Motility). * **Hirschsprung Disease:** Caused by the congenital absence of ganglion cells in both plexuses (starting from the internal anal sphincter and moving proximally), leading to a functional obstruction. * **Neurotransmitters:** Acetylcholine generally stimulates GI activity, while VIP (Vasoactive Intestinal Peptide) and NO (Nitric Oxide) are the primary inhibitory neurotransmitters for relaxation.
Explanation: ### Explanation **1. Understanding the Mechanism (Why B is Correct)** The absorption of glucose in the small intestine involves two distinct transport mechanisms: * **Apical Membrane (Lumen to Cell):** Glucose enters via **SGLT-1** (Sodium-Glucose Linked Transporter). This is **Secondary Active Transport**. It uses the energy from the Na+ gradient (maintained by Na+,K+ ATPase) to "pump" glucose into the cell, even against a steep concentration gradient. Because this is an active process, glucose is concentrated inside the cell to levels **higher** than those in the intestinal lumen. * **Basolateral Membrane (Cell to Blood):** Glucose exits via **GLUT-2** through **Facilitated Diffusion** (Passive Transport). For passive transport to occur, glucose must move down its concentration gradient. Therefore, for glucose to move from the cell into the blood, the intracellular concentration must be higher than the plasma concentration. Consequently, the intracellular glucose level is the "peak" concentration; it is higher than the lumen (due to active pumping) and higher than the blood (to allow passive exit). Thus, luminal levels do not exceed intracellular levels during active absorption. **2. Analysis of Incorrect Options** * **Option A & C:** If plasma glucose were equal to or much higher than cytosolic levels, glucose could not exit the cell via passive transport (GLUT-2). The gradient must favor movement from the cell to the blood. * **Option D:** This describes simple diffusion. If luminal glucose were always higher, we wouldn't need the energy-intensive SGLT-1 transporter. SGLT-1 exists specifically to ensure glucose is absorbed even when luminal concentrations are very low (e.g., between meals). **3. NEET-PG High-Yield Pearls** * **SGLT-1 vs. SGLT-2:** SGLT-1 is in the small intestine and renal tubules (S3 segment); SGLT-2 is primarily in the early proximal convoluted tubule (S1 segment) of the kidney. * **Oral Rehydration Therapy (ORT):** The co-transport of Na+ and glucose via SGLT-1 is the physiological basis of ORS. Sodium absorption enhances water absorption. * **GLUT-2:** This is a high-capacity, low-affinity transporter found in the liver, pancreas, and basolateral membrane of the intestine/kidney.
Explanation: **Explanation:** The absorption of lipids in the gastrointestinal tract depends significantly on the length of their carbon chains. **Why Direct Diffusion is Correct:** Short-chain fatty acids (SCFAs, <6 carbons) and medium-chain fatty acids (MCFAs, 6–12 carbons) are relatively water-soluble. Unlike long-chain fatty acids, they do not require complex processing. They are absorbed directly across the enterocyte membrane via **simple diffusion** and enter the **portal circulation** directly, where they bind to albumin and are transported to the liver. **Why Other Options are Incorrect:** * **Emulsification:** This is a mechanical process (aided by bile salts) that breaks down large fat globules into smaller droplets to increase the surface area for pancreatic lipase. It is a step in digestion, not the mechanism of absorption for SCFAs. * **Micelle Formation:** Long-chain fatty acids (LCFAs) and monoglycerides are hydrophobic and require bile salts to form micelles to stay in solution and reach the brush border. SCFAs are water-soluble enough to bypass this requirement. * **Chylomicron Formation:** Inside the enterocyte, LCFAs are re-esterified into triglycerides and packaged into chylomicrons to enter the **lymphatic system**. SCFAs bypass this step entirely and enter the blood directly. **High-Yield NEET-PG Pearls:** * **Site of Absorption:** SCFAs (like butyrate, propionate, and acetate) are primarily produced in the **colon** by bacterial fermentation of dietary fiber and are a major energy source for colonocytes. * **Medium-Chain Triglycerides (MCTs):** Because they are absorbed via direct diffusion into the portal vein, MCT-rich diets are clinically used for patients with malabsorption syndromes or lymphatic obstructions (e.g., chylothorax). * **Key Distinction:** Remember: **Short/Medium chain = Portal vein; Long chain = Lymphatics.**
Explanation: **Explanation:** The prevention of gastroesophageal reflux disease (GERD) depends on the **Lower Esophageal Sphincter (LES)** maintaining a pressure gradient higher than the intragastric pressure. **Why Option D is correct:** **Increased intrathoracic pressure** actually **promotes** reflux rather than preventing it. The esophagus is located in the thoracic cavity, where pressure is normally sub-atmospheric (negative). If intrathoracic pressure increases (e.g., during coughing or straining), it can decrease the pressure gradient across the LES or pull the esophagus upward, weakening the anti-reflux barrier and facilitating the backflow of gastric acid. **Why the other options are incorrect:** * **A. Long intraabdominal esophagus:** A segment of the esophagus (approx. 2-4 cm) lies within the abdomen. Because it is exposed to positive intraabdominal pressure, this pressure acts externally to compress the esophageal walls, helping to keep the LES closed. * **B. Increased intraabdominal pressure:** While extreme increases (like obesity) can cause reflux, physiological increases in intraabdominal pressure actually help "pinch" the intraabdominal segment of the esophagus shut, preventing reflux during activities like lifting. * **C. Right crus of diaphragm:** The esophagus passes through the esophageal hiatus formed by the right crus. This acts as an **extrinsic sphincter** (the "pinch-cock" mechanism), especially during inspiration, to prevent gastric contents from entering the esophagus. **High-Yield Clinical Pearls for NEET-PG:** * **Angle of His:** The acute angle between the esophagus and the fundus of the stomach creates a flap-valve mechanism that prevents reflux. * **Phrenoesophageal ligament:** Anchors the esophagus to the diaphragm, maintaining the position of the LES. * **Hormonal Control:** Gastrin increases LES tone, while Secretin, CCK, and Progesterone (as seen in pregnancy) decrease it.
Explanation: ### Explanation **1. Why the Correct Answer is Right:** The **Interstitial Cells of Cajal (ICCs)** are specialized mesenchymal cells located between the longitudinal and circular muscle layers of the GI tract. They function as the **electrical pacemakers** of the gut. These cells undergo spontaneous, rhythmic oscillations in their membrane potential, known as **Slow Waves** (or Basic Electrical Rhythm). The mechanism involves the cyclic opening of calcium channels and calcium-activated chloride channels, which creates a depolarization that spreads to the adjacent smooth muscle cells via **gap junctions**. It is important to note that slow waves themselves are not action potentials; they determine the *rhythm* of contractions, while action potentials (spikes) triggered at the peak of slow waves determine the *strength* of contraction. **2. Why the Incorrect Options are Wrong:** * **Options B & C (Circular and Longitudinal Muscle):** While these layers execute the mechanical contraction, they do not generate the intrinsic rhythm. They act as a functional syncytium that responds to the electrical signals initiated by the ICCs. * **Option D (Muscularis Mucosa):** This thin layer of smooth muscle is responsible for local folding of the mucosa and moving villi; it does not serve as the pacemaker for the primary peristaltic or segmental movements of the GI tract. **3. High-Yield Facts for NEET-PG:** * **Frequency Gradient:** The frequency of slow waves varies along the tract: **Stomach (~3/min) < Ileum (~8-9/min) < Duodenum (~12/min).** (Highest in the duodenum). * **Clinical Correlation:** **Gastrointestinal Stromal Tumors (GISTs)** originate from the Interstitial Cells of Cajal. They typically express the **CD117 (c-kit)** marker. * **Neural Modulation:** While slow waves are myogenic (initiated by ICCs), their amplitude can be increased by Acetylcholine (Parasympathetic) and decreased by Norepinephrine (Sympathetic).
Explanation: **Explanation:** Zollinger-Ellison Syndrome (ZES) is caused by a gastrin-secreting neuroendocrine tumor, known as a **gastrinoma**. The syndrome is defined by a classic diagnostic triad originally described by Zollinger and Ellison in 1955. 1. **Why Option A is correct:** * **Non-beta cell tumor:** Gastrinomas typically arise from the G-cells of the pancreas or the duodenum. Since they do not originate from the insulin-producing beta cells of the islets of Langerhans, they are classified as non-beta cell islet tumors. * **Gastric hypersecretion:** The tumor secretes excessive amounts of gastrin, which stimulates the parietal cells to produce massive quantities of hydrochloric acid (HCl). * **Peptic ulceration:** The resulting hyperchlorhydria leads to aggressive, recurrent, and often multiple peptic ulcers, frequently located in atypical sites like the distal duodenum or jejunum. 2. **Why other options are incorrect:** * **Options B & D:** These mention "beta cell tumors," which are associated with **Insulinomas** (causing hypoglycemia), not gastrinomas. * **Options C & D:** These mention "achlorhydria" (absence of HCl). ZES is characterized by the exact opposite—**hyperchlorhydria**. Achlorhydria is seen in conditions like Pernicious Anemia or VIPoma (WDHA syndrome). **NEET-PG High-Yield Pearls:** * **Location:** Most gastrinomas are found in the **"Gastrinoma Triangle"** (bounded by the confluence of the cystic/common bile duct, junction of the 2nd and 3rd parts of the duodenum, and the neck/body of the pancreas). * **Association:** Approximately 25% of ZES cases are associated with **Multiple Endocrine Neoplasia type 1 (MEN1)**. * **Diagnosis:** The best initial screening test is **fasting serum gastrin levels** (>1000 pg/mL is diagnostic). The most specific provocative test is the **Secretin Stimulation Test** (Secretin normally inhibits gastrin, but in ZES, it causes a paradoxical rise). * **Clinical Feature:** Chronic diarrhea is a common symptom due to the inactivation of pancreatic enzymes by low intestinal pH.
Explanation: ### Explanation **Correct Answer: C. Interstitial cells of Cajal** **Mechanism:** Slow waves (also known as the Basic Electrical Rhythm) are spontaneous, oscillating membrane potentials that occur in the gastrointestinal (GI) smooth muscle. They are generated by the **Interstitial cells of Cajal (ICC)**, which act as the "electrical pacemakers" of the gut. These cells form a network between the longitudinal and circular muscle layers. The ICCs undergo cyclic changes in membrane permeability (specifically involving calcium and potassium channels), which create the slow-wave rhythm that propagates to the adjacent smooth muscle via gap junctions. **Analysis of Incorrect Options:** * **A. Myenteric neurons:** While the Myenteric (Auerbach’s) plexus regulates the *intensity* and *frequency* of GI contractions by releasing neurotransmitters, it does not generate the intrinsic slow-wave rhythm. * **B. Smooth muscle:** Smooth muscle cells respond to slow waves by contracting (if the threshold is reached), but they do not initiate the rhythm themselves; they are the effectors, not the pacemakers. * **D. Parasympathetic neurons:** The Vagus nerve (parasympathetic) increases the amplitude of slow waves and the probability of spike potentials, but the underlying rhythm persists even in the absence of external innervation. **High-Yield NEET-PG Pearls:** * **Frequency Gradient:** The frequency of slow waves varies along the tract: **Stomach (~3/min)** < **Ileum (~8-9/min)** < **Duodenum (~12/min)**. The duodenum has the highest frequency. * **Spike Potentials:** Slow waves themselves do not cause contraction. Contraction occurs only when **spike potentials** (true action potentials) are superimposed on the crest of the slow wave, triggered by calcium entry. * **Clinical Correlation:** Loss or dysfunction of ICCs is implicated in motility disorders such as **Gastroparesis** and **Chronic Intestinal Pseudo-obstruction**.
Gastrointestinal Motility
Practice Questions
Gastrointestinal Secretions
Practice Questions
Digestion and Absorption
Practice Questions
Gastrointestinal Hormones
Practice Questions
Hepatobiliary Physiology
Practice Questions
Pancreatic Exocrine Function
Practice Questions
Gastrointestinal Circulation
Practice Questions
Intestinal Immune System
Practice Questions
Gut Microbiome
Practice Questions
Regulation of Food Intake
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free